| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |